Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Shinichi Hasako"'
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Body weight change resulting from once-daily oral administration of TAS6417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a476858e30bac48361a3b8a662fca9
https://doi.org/10.1158/1535-7163.22504678
https://doi.org/10.1158/1535-7163.22504678
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Methods for in vitro kinase assay, genome sequence, and immunoblotting analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce204b285b40a49955705f9edab87ea
https://doi.org/10.1158/1535-7163.22504675
https://doi.org/10.1158/1535-7163.22504675
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Establishment of a cell line tool with an EGFR exon 20 insertion mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d326aa592f7fd02a2e2e80cf4473a9a5
https://doi.org/10.1158/1535-7163.22504681
https://doi.org/10.1158/1535-7163.22504681
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Inhibitory activity and kinase selectivity of TAS6417 in biochemical assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98115ea47514a42df04ed14bdc97b39c
https://doi.org/10.1158/1535-7163.22504669.v1
https://doi.org/10.1158/1535-7163.22504669.v1
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Synthesis procedures and characterization data for the synthesis of TAS6417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7ddf132d5a5a6052d5ce62197c42f2
https://doi.org/10.1158/1535-7163.22504684
https://doi.org/10.1158/1535-7163.22504684
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Assignment of MSE fragmentation data for protease-digested peptide with TAS6417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52cc6e1d19e15a2d36ceaeca2605d05c
https://doi.org/10.1158/1535-7163.22504672.v1
https://doi.org/10.1158/1535-7163.22504672.v1
Autor:
Susumu S. Kobayashi, Daniel B. Costa, Koichi Goto, Kazutaka Miyadera, Hiroyuki Yasuda, Kaoru Funabashi, Akihiro Hashimoto, Ryoto Fujita, Miki Terasaka, Tomonori Haruma, Toshiharu Komori, Naomi Abe, Mikiko Shibuya, Yumi Hakozaki, Rumi Fujioka, Akihiro Ohashi, Shinichi Hasako, Hibiki Udagawa
Despite the worldwide approval of three generations of EGFR tyrosine kinase inhibitors (TKI) for advanced non–small cell lung cancers with EGFR mutations, no TKI with a broad spectrum of activity against all clinically relevant mutations is current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2b4144c587c8b3963be86abe980c10
https://doi.org/10.1158/1541-7786.c.6541192
https://doi.org/10.1158/1541-7786.c.6541192
Autor:
Kenichi Matsuo, Kazuhiko Yonekura, Yoshimi Aoyagi, Kazutaka Miyadera, Renu Wadhwa, Takashige Okayama, Kenji Tanaka, Ryoto Fujita, Akihiro Hashimoto, Hirokazu Ohsawa, Takao Uno, Naomi Abe, Miki Terasaka, Shinichi Hasako
Activating mutations in the EGFR gene are important targets in cancer therapy because they are key drivers of non–small cell lung cancer (NSCLC). Although almost all common EGFR mutations, such as exon 19 deletions and the L858R point mutation in e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84f404448e0d3ab520d3836282e8d4a7
https://doi.org/10.1158/1535-7163.c.6537826.v1
https://doi.org/10.1158/1535-7163.c.6537826.v1
Autor:
Susumu S. Kobayashi, Daniel B. Costa, Koichi Goto, Kazutaka Miyadera, Hiroyuki Yasuda, Kaoru Funabashi, Akihiro Hashimoto, Ryoto Fujita, Miki Terasaka, Tomonori Haruma, Toshiharu Komori, Naomi Abe, Mikiko Shibuya, Yumi Hakozaki, Rumi Fujioka, Akihiro Ohashi, Shinichi Hasako, Hibiki Udagawa
Supplementary Table 1. IC50 values of Ba/F3 cells expressing common mutations in the presence or absence of the T790M to EGFR TKIs tested. Supplementary Table 2. IC50 values of Ba/F3 cells expressing uncommon mutations in the presence or absence of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489431f0c3da5b5bdf69b0f6bb035567
https://doi.org/10.1158/1541-7786.22515805
https://doi.org/10.1158/1541-7786.22515805
Autor:
Yoshikazu Iwasawa, Hidehito Kotani, Mitsuru Ohkubo, Nobuhiko Kawanishi, Satomi Miki, Ikuko Takahashi, Mayu Miyamoto, Tadahiro Nambu, Takumi Sakai, Tsutomu Kodera, Koji Ichikawa, Takashi Mita, Yoko Nakatsuru, Shinichi Hasako, Toshiyasu Shimomura
Supplementary Figure 1 from MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b079111e339740d4c7ac9bebcc68c05
https://doi.org/10.1158/1535-7163.22484802
https://doi.org/10.1158/1535-7163.22484802